Show simple item record

dc.creatorNOEMÍ H.,ISABEL
dc.creatorVIOVY A.,ALEJANDRO
dc.creatorZAMORANO P.,ROCÍO
dc.creatorBLANCO M.,ÁNGEL
dc.creatorREVELLO P.,DANIEL
dc.creatorVOJKOVIC L.,MLADEN
dc.creatorCERVA C.,JOSÉ LUIS
dc.date2003-01-01
dc.date.accessioned2020-02-17T15:31:30Z
dc.date.available2020-02-17T15:31:30Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182003000400002
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/129669
dc.descriptionThe aim of this study was to observe the response of hydatid disease in children to albendazole, either combined with or without surgery. The study was performed at Dr. L. Calvo Mackenna Hospital, between 1997 and 2000, in 15 patients. Thirteen patients received post surgery treatment because of daughter cyst finding and 2 received chemotherapy only. Albendazole was given orally (dose: 5 mg/kg bid for a mean time of 25 days) in 1 to 5 courses. Treatment evaluation was based on changes in cyst morphology, sonography and computed tomography, hematological and serological analysis. Seven patients had full response; the other had clinical and serological improvement. According with previously published experience, albendazole was efficient as a paliative pharmacological treatment instead of surgical procedure, in case of non-practicable hydatid cyst surgery. Moreover, albendazole is useful in case of multiple daughter cysts, well tolerated and reduced side effects in the follow-up.
dc.formattext/html
dc.languagees
dc.publisherSociedad Chilena de Infectología
dc.relation10.4067/S0716-10182003000400002
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista chilena de infectología v.20 n.4 2003
dc.subjectHydatid disease
dc.subjectEchinococcus granulosus
dc.subjectalbendazole
dc.titleHidatidosis en la infancia: Albendazol en su tratamiento médico y quirúrgico


This item appears in the following Collection(s)

Show simple item record